GSK To Buy Sierra Oncology For $1.9 Billion In Boost To Blood Cancer Ops

GSK To Buy Sierra Oncology For $1.9 Billion In Boost To Blood Cancer Ops

(Reuters) -Britain’s GlaxoSmithKline has agreed to buy California-based biopharmaceutical company Sierra Oncology in a cash deal valued at $1.9 billion, the companies said on Wednesday, as it seeks to bolster its blood cancer business. Shareholders in Sierra, which focuses on targeted therapies for the treatment of rare forms of cancer, will receive $55 per share…

Read More
Japan's SMFG, Tepco, Mitsubishi Face Activist Climate Votes At AGMs

Japan’s SMFG, Tepco, Mitsubishi Face Activist Climate Votes At AGMs

By Makiko Yamazaki TOKYO (Reuters) – Big Japanese firms including Sumitomo Mitsui Financial Group, Tokyo Electric Power (Tepco) and Mitsubishi Corp will face resolutions from activist shareholders urging greater commitment to tackling climate change at their annual meetings this year. Five climate activist groups, including Japan’s Kiko Network and Australia’s Market Forces, said in a…

Read More